(Total Views: 314)
Posted On: 09/21/2019 10:01:38 AM
Post# of 145254
I can foresee very many indications for leronlimab, but 100 seems to the high side. But quite a few of those indications will be multi-billion and just with hiv, cancer and nash it could approach your high side figure. That's why I laugh at selling off at $5 a share.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)